AbbVie
Last updated: . For recent data, use our API.
Overview
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. The company works closely with patients and physicians to address the complex challenges they face, and its research in cancer medicine includes work on antibody drug conjugates.
AbbVie has more than 250 active external innovation partners for discovering and developing new medicines. Its research culture brings together people from different disciplines, and employees have access to functional training, global events and leadership programs. The company also carries out pharmaceutical manufacturing in the United States. Its sustainability work covers environmental, social and governance topics, including environmental stewardship.
Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
Private funding before listing
Disclosed funding: $1.2M across 1 round. Latest: Post-IPO Debt, 6 Aug 2026.
| Date | Type | Amount |
|---|---|---|
| 6 Aug 2026 | Post-IPO Debt | $9.5B |
Office locations
- North Chicago, Illinois, US
- Cambridge, Massachusetts, US
- Mettawa, Illinois, US
- Redwood City, California, US
- Madison, New Jersey, US
- Irvine, California, US
- Shanghai, CN
- Markham, Ontario, CA
- Seoul, KR
- Shibuya-Ku, JP
- Heredia, CR
- Madrid, Community of Madrid, ES
- Buenos Aires, Autonomous City of Buenos Aires, AR
- Gordon, New South Wales, AU
- Vienna, AT
- Manama, Capital Governorate, BH
- Dhaka, BD
- Banani, BD
- Saint Michael, BB
- Diegem, Flemish Region, BE
- Cochabamba, BO
- São Paulo, Sao Paulo, BR
- Guarulhos, Sao Paulo, BR
- Las Condes, Santiago Metropolitan Region, CL
- Bogota, CO
- CZ
- Santo Domingo, Distrito Nacional, DO
- Quito, EC
- Cairo, EG
- Sierra Vista, Arizona, US
- Upplands-Väsby, SE
- Frankfurt, Hessen, DE
- Athens, Attica, GR
- Guatemala, GT
- Tegucigalpa, HN
- HK
- Budapest, HU
- Bengaluru, Karnataka, IN
- ID
- Dublin, IE
- Petah Tikva, IL
- Rome, IT
- Kingston, JM
- Amman, JO
- KW
- Beirut, LB
- Selangor, MY
- Cuajimalpa de Morelos, Ciudad de México, MX
- Breda, North Brabant, NL
- Auckland, NZ
- Karāchi, Sindh, PK
- PS
- Jenkintown, Pennsylvania, US
- Santiago de Surco, PE
- Lima, PE
- Pasig, PH
- Warsaw, MA, PL
- Carnaxide, PT
- San Juan, PR
- Guaynabo, PR
- Bucharest, RO
- Moscow, RU
- Jeddah, SA
- Belgrade, Central Serbia, RS
- Singapore, SG
- Bratislava, SK010, SK
- Johannesburg, ZA
- Cape Town, Western Cape, ZA
- Colombo, Western Province, LK
- Stockholm, SE
- Zurich, CH
- Taipei, TW
- Hsin-tien, TW
- Bangkok, TH
- TH
- Port of Spain, TT
- Istanbul, TR
- Kyiv, UA
- Dubai, AE
- Marlow, England, GB
- Antrim, Northern Ireland, GB
- Liverpool, England, GB
- Londonderry, Northern Ireland, GB
- Washington, District of Columbia, US
- Montevideo, UY
- Caracas, Federal District, VE
- Ho Chi Minh City, VN
- Sana'a, YE
- Mascot, New South Wales, AU
- Ludwigshafen, Rheinland-Pfalz, DE
- Wiesbaden, Hessen, DE
- Berlin, DE
- Copenhagen, DK
- London, England, GB
- Brussels, BE
- Rungis, FR
- Helsinki, FI
Similar companies
- Eli Lilly and CompanyPharmaceutical Manufacturing · Indianapolis, Indiana
- PfizerPharmaceutical Manufacturing · New York
- AmgenBiotechnology Research · Thousand Oaks, CA
- SanofiPharmaceutical Manufacturing · Paris, France
- AstraZenecaPharmaceutical Manufacturing · Cambridge, Cambridgeshire
- NovartisPharmaceutical Manufacturing · Basel, Baselstadt
- RocheBiotechnology Research
- AbbottHospitals and Health Care · Abbott Park, Illinois
- GSKPharmaceutical Manufacturing · London, England
- Johnson & JohnsonHospitals and Health Care · New Brunswick, NJ
Latest videos from AbbVie on YouTube
The Persistence Lab | Episode 10 – Inside the Mind of a Scientist
Catalyzing Community-led Innovation: The 2026 AbbVie Foundation Health Equity Accelerator
Shared Values, Shared Purpose: AbbVie and Major League Baseball
The Persistence Lab | Episode 9 – Can Scientists Slow Down Brain Disorders?
Recent posts from the AbbVie blog
- This year at #UEGWeek, we’re presenting new research highlighting AbbVie’s ongoing dedication to advancing…
care for people living with #IBD. To learn more about our work in #UlcerativeColitis and #CrohnsDisease, visit. [Video description: On-screen text reads: “At this year’s UEG Week, AbbVie will showcase the latest IBD data demonstrating our continued determination to advance the standards of care.
- Despite treatment advances, many people living with #IBD stop responding to treatment over time, while others…
never achieve remission. How can research help push past these limits?